← Back to all briefings

D.C. Shooting, Trump's Bill, Biden's Health & RFK Jr.'s Report

May 23, 2025

Table of Contents

Key Updates

D.C. Embassy Attack: Charges Filed, Motive Probed in Killing of Israeli Staffers

The fatal shooting of two Israeli Embassy staffers, Yaron Lischinsky and Sarah Lynn Milgrim, outside the Capital Jewish Museum in Washington, D.C. on Wednesday, escalated significantly with formal charges laid against the suspect, Elias Rodriguez. As reported yesterday, the attack itself was a shocking development; today, we see the judicial process kicking in. Rodriguez now faces murder charges, including murder of foreign officials, and firearm offenses. The investigation is clearly being treated with utmost seriousness, labeled a potential hate crime and act of domestic terrorism.

Reports indicate Rodriguez shouted "Free Palestine" or similar pro-Palestinian slogans during or after the attack. His apartment in Chicago was reportedly raided by the FBI as investigators dig into his background and motivations. The victims, Lischinsky and Milgrim, were a couple and reportedly about to be engaged, adding another layer of tragedy. This incident has, predictably, sent ripples of concern regarding the safety of diplomats and Jewish institutions, with calls for increased security.

Analytical Take: This wasn't just a random act of violence; the targeting of embassy personnel and the suspect's reported statements point directly to a politically motivated crime, likely fueled by the Israeli-Palestinian conflict. The speed with which "hate crime" and "terrorism" are being invoked underscores the gravity. Expect this to further polarize an already intense debate, both domestically and internationally. The "lone wolf" versus "inspired by" discussion will be front and center, and it will inevitably put pressure on social media platforms and political rhetoric that touches these sensitive nerves. This is the kind of event that can easily be exploited for broader political agendas, so watch the narratives forming around it.

Trump's "One Big Beautiful Bill" Scrapes Through the House, Heads to a Senate Showdown

President Trump's signature legislative package, dubbed the "One Big Beautiful Bill," managed to pass the House of Representatives on Thursday, but just barely – by a 215-214 vote. This is a win for Trump and House Speaker Mike Johnson, sure, but that margin is a flashing red light signaling some serious jitters even within the Republican ranks. The bill, as discussed yesterday while it was developing, bundles extensions of the 2017 tax cuts with increased border security funding and, crucially, proposed cuts to Medicaid and SNAP (food stamps).

The narrow victory came despite some initial resistance from the House Freedom Caucus, who were apparently brought on board with some concessions. Now, this legislative beast lumbers over to the Senate, where it’s expected to face a far chillier reception and significant opposition. Concerns about its impact on the national debt and the potential for triggering Medicare cuts (due to PAYGO rules, unless waived) are already being loudly voiced.

Analytical Take: That one-vote margin in the House is the real story here. It demonstrates the tightrope Speaker Johnson is walking and the leverage that small factions within the GOP hold. If they can barely whip their own party into line in the House, the Senate looks like a legislative minefield. The bill itself is a classic cocktail of conservative priorities: tax cuts (disproportionately benefiting higher earners and corporations, if history is a guide), beefed-up security spending, and cuts to social safety nets. The inclusion of "Trump accounts" for newborns is a novel, populist-sounding sweetener, but the fiscal implications of the whole package will be heavily scrutinized. This bill is less a done deal and more the opening salvo in a protracted political war.

Executive Overreach or Judicial Activism? Trump Admin Clashes With Courts on Multiple Fronts

The Trump administration is finding itself increasingly entangled in legal battles, with federal judges pushing back on several key policy initiatives. On Thursday, a federal judge blocked the administration's attempt to dismantle the Department of Education, a long-held conservative goal. Another judge blocked a move to terminate the legal status of international students en masse, though this didn't stop the administration from specifically terminating Harvard University's student visa program, citing alleged "pro-terrorist conduct" and failure to report certain foreign funding – a move spearheaded by Kristi Noem.

This follows a ruling on Wednesday where a federal judge found that the Department of Homeland Security (DHS) violated a court order by deporting eight illegal immigrants to South Sudan, a situation that was escalating yesterday. The Supreme Court has also been weighing in on various disputes, sometimes siding with the administration, sometimes limiting its authority, reflecting the deep divisions even at the highest judicial level. Adding an international wrinkle, Taiwan is reportedly increasing scrutiny of Chinese immigrants due to espionage concerns, a move that aligns with the administration's broader hawkish stance on China.

Analytical Take: This is the judiciary acting as a significant check on executive power, just as the founders intended – or, if you're in the administration's camp, it's activist judges thwarting the will of the elected government. The targeting of the Department of Education and universities like Harvard (using some pretty incendiary language about "pro-terrorist conduct") is red meat for Trump's base and signals a deepening commitment to the culture war. The South Sudan deportation ruling highlights the administration's aggressive immigration posture bumping up against legal constraints. The Harvard visa program termination is particularly pointed; expect legal challenges and a major outcry from academia. This pattern of executive action followed by judicial review and often, reversal or modification, is likely to be a defining feature of this term.

Biden's Post-Presidency: Cancer Diagnosis, "Original Sin" Book, and Cover-Up Allegations

Former President Joe Biden's health, a topic of intense speculation during and after his presidency, is back in the spotlight. As reported yesterday, allegations of a cover-up regarding his cognitive decline were intensifying. This has now been amplified by the Tuesday release of the book, 'Original Sin: President Biden’s Decline, Its Cover-Up, and His Disastrous Choice to Run Again,' co-authored by journalists Jake Tapper and Alex Thompson. The book reportedly details concerns among lawmakers and alleges that Biden's staff, including former Press Secretary Karine Jean-Pierre, concealed the extent of his cognitive issues.

Adding to this, Biden announced on May 18th that he has been diagnosed with stage 4 prostate cancer. This confluence of events has reignited debate about transparency regarding leaders' health, the media's role in covering such sensitive issues, and has prompted House Republicans to launch an investigation into the alleged cover-up.

Analytical Take: The timing of the cancer diagnosis announcement, just before the book's release detailing alleged cognitive decline, is, to put it mildly, conspicuous. Whether it's a straightforward health update or a strategic move to manage the narrative around the book's damaging claims is an open question. The book itself, penned by established journalists, will carry weight and force a renewed examination of Biden's final year in office and his decision to initially seek re-election. The "media complicity" angle, a common refrain from critics, will also get a workout. This story isn't just about Biden's health; it's about trust, transparency, and the often-uncomfortable intersection of personal health and public office.

White House Crypto: Trump's $TRUMP Coin Dinner Raises Eyebrows and Ethics Alarms

President Trump hosted a private dinner on Thursday at his Virginia golf course for top holders of his meme coin, $TRUMP. This event, previewed in April, was for individuals who had spent significant sums on the cryptocurrency, which was launched by the Trump family shortly before his inauguration in January 2025. Unsurprisingly, this has set off alarm bells regarding potential conflicts of interest and the possibility of foreign entities buying access or influence. Noted crypto figure Justin Sun, a Chinese-born billionaire and major $TRUMP holder who has had his own run-ins with the SEC, was reportedly in attendance.

The White House, through Press Secretary Karoline Leavitt, has dismissed these concerns, stating Trump's assets are in a blind trust. Critics, however, are not convinced, particularly given the direct link between the coin's value and Trump's public persona and actions.

Analytical Take: The term "blind trust" often feels like a fig leaf in situations like this, especially when the asset is a meme coin literally bearing the President's name. It's hard to argue the beneficiary is "blind" to what might pump its value. This event is a fascinating, if unsettling, blend of modern crypto speculation and age-old concerns about political access. The optics of a sitting president hosting a private event for big buyers of his personal crypto token are, frankly, terrible. It screams "pay-to-play" and opens the door wide for questions about what, if any, policy discussions or implicit understandings occurred. This sets a rather brazen precedent and will fuel calls for much clearer regulations around politicians and their crypto dealings. One has to wonder if the irony of a "meme coin" being at the center of a potential White House ethics scandal is lost on anyone.

NYC Transit Pains: Amtrak Tunnel Closure Proceeds Amid Congestion Pricing Standoff

New York City's commuters are bracing for more headaches as Amtrak moves forward with its planned closure of one East River Tunnel track for repairs, starting Thursday. This is happening despite vocal concerns from New York Governor Kathy Hochul and NYC Mayor Eric Adams about the potential for significant transit disruptions. This repair work was approved by the MTA back in October 2023, but the reality of it is now hitting home.

Simultaneously, the MTA is in open defiance of the US Department of Transportation (USDOT), led by Secretary Sean Duffy, over Manhattan's congestion pricing plan. The May 21st deadline for the MTA to halt the $9 tolls on drivers entering below 60th Street passed with the MTA still collecting. The MTA and NYSDOT sent letters to Duffy on Wednesday arguing against his demands and accusing him of acting improperly after he threatened to yank federal transit funding.

Analytical Take: This is a multi-front battle over who controls New York's transportation future, with commuters as the primary casualties. Amtrak's tunnel repairs are likely vital for long-term safety and reliability, but the timing couldn't be worse with the congestion pricing war raging. The MTA's decision to openly defy the USDOT is a high-stakes gamble. They're essentially calling Duffy's bluff on pulling federal funds, which are critical for the city's aging infrastructure. This conflict has all the hallmarks of a federal-versus-local power struggle, wrapped in partisan politics (given Duffy's role in a Trump administration). The outcome could have major implications not just for NYC transit but for how federal leverage is used in local infrastructure projects nationwide.

Childhood Illness in the Crosshairs: RFK Jr.-Led Commission Reports, Stirs Debate

A White House commission, the 'Make America Healthy Again' (MAHA) Commission, helmed by HHS Secretary Robert F. Kennedy Jr., released its first report on childhood chronic diseases on Thursday. Mandated by a Trump executive order from February, the report fingers poor diet, environmental chemicals, lack of physical activity/chronic stress, and "overmedicalization" as key drivers of what it calls a crisis.

As one might expect with RFK Jr.'s involvement, the report has already drawn criticism from some current and former federal health officials and industry groups, who allege misrepresentation of facts and omission of other contributing factors. The commission is slated to release a follow-up policy strategy in August.

Analytical Take: RFK Jr.'s leadership of this commission guarantees it will be controversial, given his well-known skepticism towards mainstream medical and pharmaceutical institutions. The identified culprits – poor diet, chemicals, inactivity – are not exactly novel in public health discourse. The "overmedicalization" point, however, is squarely in RFK Jr.'s wheelhouse and likely to be a major point of contention. The report's significance will ultimately hinge on the policy proposals in August. If they target specific industries (food, chemical, pharma) aggressively, expect a full-court press of lobbying and counter-arguments. This initiative allows the Trump administration to tap into a populist vein of distrust towards established institutions while ostensibly addressing a serious health concern. The real test is whether the eventual policies are evidence-based and actionable, or more ideologically driven.

D.C. Shooting, Trump's Bill, Biden's Health & RFK Jr.'s Report | The Updates